The reduction of E-cadherin levels might contribute to changes in tumor tissue growth and metastasis.[17] Consequently, these factors render the site more susceptible to the implantation of hematogenous or lymphogenous tumor cells.[18]. This evidence concerns the gene CDH1 and neoplasm.